Reading Time: 2 minutes Bayer on Wednesday raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares to a four-month high as its CEO somewhat allayed investor impatience with his turnaround efforts.
Bayer's Icafolin will be its first new mode of action herbicide in some 30 years when it launches in 2028